Tyler Patchen – Page 9 – Endpoints News

SIGN UP

about the author

Tyler Patchen

News Reporter

tpatchen@endpointsnews.com @TPatchenendpts

Tyler Patchen on LinkedIn

Tyler Patchen is a news reporter at Endpoints News. His most recent position was serving as a reporter for the Birmingham Business Journal in Birmingham, Alabama. In his time at the Business Journal, he covered a wide range of business topics including healthcare, technology, the business of sports, and universities. He also covered the startup and entrepreneurial scene for the whole state of Alabama for Alabama Inno, an adjacent publication to the Birmingham Business Journal. A graduate of Elon University, Tyler enjoys golf, travelling to unfamiliar places, attending sporting events, reading and tutoring. He is currently based out of Birmingham, Alabama.

author articles

Catalent goes into cleanup mode, replacing top managers

Last year

Manufacturing roundup: Juno Pharmaceuticals acquires Omega Laboratories; Pfizer halts distribution of four medicines

Last year

Manufacturing-centric SPAC makes a deal to combine with French CDMO

Last year

Mustang Bio to sell Massachusetts CAR-T manufacturing facility

Last year

EMA makes recommendations to manufacturers as it aims to stem drug shortages

Last year

X4 touts more positive PhIII data for its WHIM syndrome treatment

Last year

Post-recall, OTC eye drop maker handed a warning letter from the FDA

Last year

Ipca Laboratories cited for quality issues at India facility that produces API

Last year

Verve names second PCSK9 candidate; Exscientia picks another AI-created molecule for clinic

Last year

GAO: 340B program netted savings and provided benefits for low-income patients

Last year

Fusion and Cyteir refocus pipelines; Nona Biosciences collaborating with PharmaEssentia

Last year

Amylyx's Relyvrio pulls in $71M in revenue

Last year

House committee holds hearing to identify root causes of recent drug shortages

Last year

Manufacturing roundup: Quality issues at Sun Pharma plant in India; Forge secures gene therapy manufacturing contract

Last year

AAV producer NewBiologix emerges from stealth with $50M Series A

Last year

‘Pharma Bro’ Martin Shkreli's companies file for bankruptcy

Last year

CRO deal space continues to buzz as Genesis Drug Discovery buys JSS Medical Research

Last year

CRO Syneos Health to be acquired by a group of private equity firms for $7B+

Last year

After warning letters and fatal poisonings, FDA issues guidance for stringent testing of contaminants

Last year

FDA lifts partial hold on Salarius' Ewing sarcoma drug trial

Last year

Ascend launches with $130M+ as it looks to build in the AAV space

Last year

Europe looks to shore up medicines supply amid shortages

Last year

Catalent delays quarterly call as stock takes another dive

Last year

Legend Biotech looks to raise additional $350M in stock sale; Acasti commits to layoffs

Last year

First page Previous page 6 7 8910 11 12 Next page Last page